RxDoctor Payments Data

Leo Moody, MD

Family Medicine · Nashville, TNNPI 1548782568

Payments from drug & device makers

$2,091in general payments, 2019–2025

Across 124 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$430
  • Boehringer Ingelheim$343
  • Lilly USA, LLC$235
  • Amgen$155
  • Novo Nordisk$154
  • Pfizer$119
  • plus $654 from 14 others

What the payments were for

  • Food & beverage$2,091100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,091 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$10,719
Medicare patients
134
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$74,558
JardianceEmpagliflozin28$30,147
FarxigaDapagliflozin Propanediol26$23,041
EliquisApixaban30$21,645
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$21,232
VraylarCariprazine Hcl12$17,307
XareltoRivaroxaban12$15,216
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$13,158
TrulicityDulaglutide13$12,527
Tresiba Flextouch U-100Insulin Degludec13$7,597
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,419
Levetiracetam18$1,919
Albuterol Sulfate HfaAlbuterol Sulfate71$1,870
Verapamil SrVerapamil Hcl21$1,800
Gabapentin74$1,237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$154$74,55858 claims
AstraZenecaFarxiga, Breztri Aerosphere$118$36,19947 claims
Boehringer IngelheimJardiance$343$30,14728 claims
PfizerEliquis$119$21,64530 claims
GSKTrelegy Ellipta$44$21,23233 claims
AbbVieVraylar$430$17,30712 claims
Lilly USA, LLCTrulicity$235$12,52713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →